<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>PR.com Press Releases: Kylo Research Labs LLC News</title>
		<link>https://www.PR.com/</link>
		<description>Latest news releases from PR.com for Kylo Research Labs LLC.</description>
		<lastBuildDate>Wed, 07 Oct 2026 22:54:41 -0400</lastBuildDate>
		<copyright>&#169; 2026 PR.com</copyright>
		<ttl>60</ttl>
		<language>en-us</language>
		<image>
			<url>https://www.PR.com/images/logo_white.jpg</url>
			<title>PR.com Press Releases: Kylo Research Labs LLC News</title>
			<link>https://www.PR.com/</link>
			<width>68</width>
			<height>69</height>
			<description>PR.com provides press release distribution, and is a unique directory of businesses, products and services. Find full company profiles.</description>
		</image>
		<atom:link href="https://www.pr.com/rss/press-releases-2/596239.xml" rel="self" type="application/rss+xml" />
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/981036</guid>
			<title>CJC-1295 + Ipamorelin with DAC vs. No DAC: Kylo Peptides Clarifies Labeling Across Its Research Catalog</title>
			<pubDate>Wed, 07 Oct 2026 03:00:00 -0400</pubDate>
			<description>Kylo Peptides clarifies CJC-1295 + Ipamorelin labeling so researchers can tell CJC-1295 with DAC from the no-DAC form, Mod GRF 1-29, in its catalog. [PR.com]</description>
			<link>https://www.pr.com/press-release/981036</link>
			<dc:creator>Kylo Research Labs LLC</dc:creator>
		</item>
	</channel>
</rss>